Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

Authors

C. Oliver Hanemann, Peninsula Medical School
Sylwia Ammoun, Peninsula Medical School
D. Gareth Evans, Imperial College Healthcare NHS Trust
David A. Hilton, University Hospitals Plymouth NHS Trust
Adam Streeter, Peninsula Medical School
Christopher Hayward

ORCID

• C. Oliver Hanemann: 0000-0002-1951-1025
• Sylwia Ammoun: 0000-0002-1525-3583

DOI

10.1136/jnnp-2018-319713

Publication Date

2019-02-04

Publication Title

Journal of Neurology, Neurosurgery and Psychiatry

ISSN

0022-3050

Embargo Period

2019-12-07

Recommended Citation

Hanemann, C., Ammoun, S., Evans, D., Hilton, D., Streeter, A., & Hayward, C. (2019) 'Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2', Journal of Neurology, Neurosurgery and Psychiatry, . Available at: 10.1136/jnnp-2018-319713